COP vs PFE: Which Is the Better Buy?
Side-by-side comparison of ConocoPhillips and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
ConocoPhillips · Energy
$122.55
-21.4% upside to fair value
Grade D
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
PFE has more upside to fair value
(+30.1%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
COP |
PFE |
| Current Price |
$122.55 |
$26.91 |
| Fair Value Estimate |
$96.36 |
$35.00 |
| Upside to Fair Value |
-21.4%
|
+30.1%
|
| Market Cap |
$149.8B |
$153.0B |
| Forward P/E |
19.3x
|
9.5x
|
| EV / EBITDA |
5.8x
|
13.8x
|
| Price / Sales |
2.5x
|
2.4x
|
| Price / FCF |
8.9x
|
16.8x
|
| Revenue Growth YoY |
+7.5%
|
-1.6%
|
| Gross Margin |
24.6%
|
70.3%
|
| Operating Margin |
19.6%
|
24.7%
|
| Return on Equity |
12.39%
|
9.0%
|
| Dividend Yield |
3.41% |
6.4% |
| FCF Yield |
10.9%
|
5.9%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
ConocoPhillips is the largest U.S. independent exploration and production company, operating approximately 2.4 million barrels of oil equivalent per day across its Lower 48, Alaska, Canada, and international segments. The company completed its transformative $22.5 billion Marathon Oil acquisition in late 2024 and is on track for $2 billion in cost synergies by the end of 2026. Full-year 2025 reve…
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
COP |
PFE |
| Zone Low |
$72.27 |
$25.00 |
| Zone High |
$81.91 |
$29.00 |
| In Buy Zone? |
No
|
Yes
|